Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

4 Blue Chip ASX Share Ideas

Plenty of investors are drawn to the idea of blue chip names because they seem more secure and could produce more reliable growth. 
Dividends

Plenty of investors are drawn to the idea of blue chip names because they seem more secure and could produce more reliable growth.

But I don’t think that has to means shares like Commonwealth Bank (ASX: CBA) or Telstra (ASX: TLS).

Here are some blue chip growth names that (nearly) everyone knows:

A2 Milk (ASX: A2M)

A2 Milk is Australia and New Zealand’s leading infant formula business, it also offers a number of other dairy products like milk and ice cream.

Why it could be a good growth story: A2 Milk’s share price has declined quite a lot since the start of August, yet the company is still predicting solid revenue and profit growth in FY20. The China and US markets are big opportunities for growth, so I think profit could keep going up at a good rate for years.

APA Group (ASX: APA)

APA Group is the owner of a large amount of pipeline infrastructure around Australia.

Why it could be a good growth story: Energy infrastructure is very important in the current environment. APA continues to invest in new assets which should lead to higher earnings over time. It’s also a decent yield idea if interest rates keep going lower.

Crown Resorts (ASX: CWN)

Crown Resorts is the operator of two large casino complexes in Melbourne and Perth.

Why it could be a good growth story: The company is currently constructing the new major casino complex in Sydney. It’s a drain on earnings in the construction phase, but once it’s completed in a couple of years it could add significantly to earnings.

CSL (ASX: CSL)

CSL is Australia’s biggest healthcare business, it’s a biotech company that develops products like vaccines to help patient.s

Why it could be a good growth story: There are few large companies on the ASX with growth records like CSL. The fact it re-invests so much into further research & development every year unlocks future new earnings streams for the healthcare giant. It can keep growing at a good pace.

[ls_content_block id=”14947″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

Skip to content